support@moenhth.com

Moenhth impacting almost every aspect of health

Our commitment at Moenhth extends beyond mere distribution; it’s about fostering tangible improvements in health outcomes for all Australians. By seamlessly connecting patients with essential medications, we play a pivotal role in ensuring that individuals receive the treatments they need, when they need them. Through strategic partnerships and innovative approaches, we continuously strive to redefine standards in pharmaceutical distribution, ultimately contributing to a healthier, more vibrant Australia.

About Moenhth

At Moenhth, we are more than just a pharmacy distributor; we're your trusted partner in healthcare. Founded on the principles of integrity and reliability, our mission is to deliver quality pharmaceutical products while prioritizing customer satisfaction above all else. With a relentless commitment to excellence, we strive to exceed industry standards and continuously improve our services to meet the evolving needs of our customers. At Moenhth, your health and well-being are our top priorities, driving us to uphold the highest standards of quality, transparency, and professionalism in everything we do.

Moenhth
Moenhth
Moenhth

Addressing Drug Shortages

We are dedicated to assisting in the resolution of the various problems causing medication shortages, and we have extensive experience in pharmaceutical distribution, supply chain analytics, and market access dynamics.

Delivering on Innovative Medical Breakthroughs

Discover how Moenhth Pharmaceutical Distribution facilitates the seamless supply of essential medications, ensuring widespread access and efficient delivery to healthcare providers and patients, thereby enhancing healthcare outcomes and advancing medical accessibility.

Supply Chain Global & Resilience

We provide global distribution solutions tailored to ensure seamless access to vital medications worldwide. From advanced supply chain strategies to meticulous logistics management, count on us for reliability and resilience.

Providing an Oasis to Pharmacy Deserts

Moenhth innovative approach aims to tackle pharmacy deserts in an underserved community.

Our Clients

Moenhth
Moenhth consistently goes above and beyond to meet our pharmacy's needs. Their extensive product range and prompt delivery ensure that we can always provide our customers with the medications they need, when they need them.

Charlie Anderson

MedSolutions Pharmacy

Moenhth
As a healthcare professional, I rely on Moenhth to provide my clinic with high-quality pharmaceuticals. Their dedication to customer satisfaction and attention to detail make them an invaluable partner in our mission to provide exceptional care to our patients.

Dr. David Patel

MedLife Clinics

Moenhth
Moenhth has been our go-to pharmacy distributor for years. Their commitment to quality and reliability is unmatched in the industry. We trust them implicitly to deliver top-notch products on time, every time

Emily Smith

HealthWell Pharmacies

Moenhth
Partnering with Moenhth has been a game-changer for our pharmacy. Their dedication to excellence and customer satisfaction align perfectly with our own values, making them an indispensable asset to our business

Sarah Johnson

CarePoint Pharmacy

Contact Moenhth

Reports

Recent

Moenhth

Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib

Excellent Outcomes Seen for Radiofrequency Catheter Ablation for Paroxysmal A-Fib OVERVIEW Clinical outcomes are excellent with use of radiofrequency (RF)...

Read More
Moenhth

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer OVERVIEW NEW YORK & COPENHAGEN, Denmark–(BUSINESS WIRE)– Pfizer...

Read More
Moenhth

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea Introduction Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar...

Read More
Moenhth

Influenza (Flu) Antiviral Drugs and Related Information

Influenza (Flu) Antiviral Drugs and Related Information Introduction The term influenza refers to illness caused by influenza virus. This is...

Read More
Moenhth

Tamiflu FDA Review

Tamiflu FDA Review Review Tamiflu (oseltamivir phosphate) is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza...

Read More
Moenhth

Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates

Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates OVERVIEW For patients with metastatic or advanced cancer, treatment...

Read More
Moenhth

Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season

Mortality Higher for COVID-19 Hospitalization Than for Flu in 2023/2024 Season OVERVIEW In fall/winter 2023/2024, the risk for death in...

Read More
Moenhth

Study Identifies Factors That Predict Driving Cessation in Seniors

Study Identifies Factors That Predict Driving Cessation in Seniors OVERVIEW Among older adults, factors associated with future driving cessation include...

Read More
Moenhth

Relenza Pharmocology

Relenza (Zanamivir) Pharmocology Introduction Zanamivir is the pharmaceutically active component of the antiviral medication Relenza. This drug stops the replication...

Read More
Moenhth

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults OVERVIEW For adolescents and young adults, glucagon-like...

Read More
Moenhth

Relenza FDA Review

Relenza (zanamivir) FDA Review Introduction Relenza (zanamivir) is an inhalation powder for oral inhalation approved for treatment of acute uncomplicated...

Read More
Moenhth

Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium

Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium OVERVIEW Ongoing leisure-time physical activity, even at high volumes,...

Read More
Moenhth

Global Life Expectancy, Disease Burden Set to Keep Improving

Global Life Expectancy, Disease Burden Set to Keep Improving OVERVIEW Life expectancy and age-standardized disease burden are expected to continue...

Read More
Moenhth

FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus

Influenza (Flu) Antiviral Drugs and Related Information OVERVIEW The U.S. Food and Drug Administration has approved a 200-mg subcutaneous route...

Read More
Moenhth

FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea

FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea OVERVIEW Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar...

Read More
Moenhth

Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children

Ultraprocessed Foods Increase Adiposity, Cardiometabolic Risk in Children OVERVIEW  High ultraprocessed food (UPF) consumption in young children is associated with...

Read More
Moenhth

Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject™ Units and Labetalol Hydrochloride Injection, USP Carpuject™ Units Due To The Potential For Incomplete Crimp Seals

Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection Carpuject,Due To The Potential For Incomplete Crimp Seals OVERVIEW...

Read More